日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Induction immunochemotherapy before definitive chemoradiotherapy versus definitive chemoradiotherapy alone in limited-stage small-cell lung cancer: a multicenter propensity score-matched analysis

在局限期小细胞肺癌中,诱导免疫化疗后行根治性放化疗与单纯根治性放化疗的疗效比较:一项多中心倾向评分匹配分析

Hou, Xin; Guo, Yihan; Yan, Meng; Zhang, Yangyang; Zhang, Zheng; Sun, Yanglin; Ren, Kai; Li, Xue; Ding, Xin; Zhao, Lujun

CES3 promotes NSCLC progression via lipid metabolic reprogramming regulated by TFAP2A.

CES3 通过 TFAP2A 调控的脂质代谢重编程促进非小细胞肺癌的进展。

Luo Pengfei, Huang Zirui, Ding Sijuan, Tang Zhangwen, Wei Yanhong, Jiang Shaohui, Tang Ruoting, Li Fang, Yang Han, Zhao Lujun

Thoracic radiotherapy may enhance the survival of patients with low-risk advanced lung adenocarcinoma based on protein biomarkers

基于蛋白质生物标志物,胸部放射治疗可能提高低危晚期肺腺癌患者的生存率。

Meng, Chunliu; Wang, Fang; Wang, Juan; Tian, Jia; Li, Xue; Lu, Haijun; Zhao, Lujun; Wang, Ping

Induction chemoimmunotherapy may achieve non-inferior outcomes to consolidation immunotherapy in patients with unresectable stage III NSCLC: a real-world multicenter retrospective study

对于不可切除的III期非小细胞肺癌患者,诱导化疗联合免疫疗法可能取得不劣于巩固免疫疗法的疗效:一项真实世界多中心回顾性研究

Guan, Song; Wang, Yu; Liu, Qing; Yan, Meng; Ren, Kai; Wang, Jun; Bi, Nan; Zhao, Lujun

Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas

三联疗法彻底改变了以往无法治疗的伴有高流量肝动静脉瘘的肝细胞癌的治疗模式

Li, Jinpeng; Li, Yuanming; Zhong, Jingtao; Du, Jiasheng; Chen, Jiao; Shi, Jutian; Zhao, Lujun; Song, Jinlong

Correction: Triple therapy revolutionizes treatment paradigms for previously untreatable HCC complicated by high-flow hepatic arteriovenous fistulas

更正:三联疗法彻底改变了以往无法治疗的伴有高流量肝动静脉瘘的肝细胞癌的治疗模式。

Li, Jinpeng; Li, Yuanming; Zhong, Jingtao; Du, Jiasheng; Chen, Jiao; Shi, Jutian; Zhao, Lujun; Song, Jinlong

Development of a prognostic model for patients with extensive-stage small cell lung cancer undergoing immunotherapy and chemotherapy

为接受免疫治疗和化疗的广泛期小细胞肺癌患者建立预后模型

Gao, Yunbin; Zhang, Lixia; Yan, Meng; Sun, Zongwen; Zhao, Haibo; Zhao, Lujun

Low dose radiotherapy combined with immune checkpoint inhibitors induces ferroptosis in lung cancer via the Nrf2/HO-1/GPX4 axis.

低剂量放射疗法结合免疫检查点抑制剂可通过 Nrf2/HO-1/GPX4 轴诱导肺癌细胞发生铁死亡

Luo Jing, Zhi Qiongjie, Li Dongxia, Xu Yue, Zhu Hui, Zhao Lujun, Ren Guibing, Wang Jian, Liu Ningbo

COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma.

COL7A1 显示出作为肺腺癌基底膜相关预后生物标志物和治疗靶点的关键潜力

Zhang Jiao, Zi Rui, Hu Ping, Jiang Zongying, Lv Ye, Zhang Haixia, Zhao Yanjiao, Wang Yan, Zhao Lujun

Clinical features and outcomes of unresectable locally advanced lung adenocarcinoma with uncommon EGFR mutations: a retrospective multi-center Chinese study

不可切除的局部晚期肺腺癌伴罕见EGFR突变的临床特征和预后:一项回顾性多中心中国研究

Xu, Kunpeng; Zheng, Xiao-Li; Chen, Ming; E, Mingyan; Zhang, Li; Cao, Jianzhong; Zhang, Xu; Ding, Xiao; Xia, Bing; Zhao, Lujun; Wang, Hongbin; Li, Jiancheng; Hu, Chen; Jiang, Wei; Ge, Hong; Bi, Nan; Wang, Luhua